single blue molecule some purple surrounding

Myeloma is the second most common haematological cancer and accounts for 2% of all malignancies, yet it continues to have a worse prognosis than other haematological cancers. This module will discuss the presentation of myeloma, including those who present without pain, how to investigate in primary care and when to refer. The primary care aspects of treatment will also be discussed, as will the management of monoclonal gammopathy of uncertain significance, an increasingly commonly recognised precursor condition to myeloma.

An educational grant was received from Binding Site for the production of the course.  Editorial and content decisions were made solely by the RCGP.

binding site

Curriculum: Haematology
Time to complete this course: 30 minutes
Date of publication: 10 September 2019
Reviewed and updated: 10 May 2022
Mode: Course
Podcast icon: No
Course index: Show
Section titles: Hide
Breadcrumb: Hide